TSX/TLRY (TSX/TLRY)

Toronto Stock Exchange: TSX/TLRY · CAD

CA$3.69

-0.05 (-1.3%)· Recorded snapshot

Market cap	546.3M
Revenue (ttm)	1.3B
Net income (ttm)	-227.7M
EPS (ttm)	-CA$1.94
P/E (forward)	15.9x
Volume	528,278
Beta	1.92

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.3B
Net income (ttm): -227.7M
EPS (ttm): -CA$1.94
P/E (forward): 15.9x
Market cap: 546.3M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E15.9

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-9.4

P25 n/aP50 n/aP75 n/a

ROIC-3.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TSX/TLRY indicators

Market & fundamental data

Available fields

193

Groups with data

Currency

USD

Showing 193 of 193 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	United States
Country code	CA
Earnings date	2026-10-08
Employees	3,595
Employees change	192
Employees growth	7.25%
Enterprise value	CAD 738.9M
Exchange	Toronto Stock Exchange
Financial currency	USD
Financial report date	2026-08-31
First seen	2026-05-10
Fiscal year end	May
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
ISIN number	US88688T2096
Last earnings date	2026-10-08
Last refreshed	2026-10-29
Last stock split date	2025-12-02
Last stock split type	Reverse
Market cap	CAD 546.3M
Next earnings date	2027-01-08
Price	CAD 3.69
Price currency	CAD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-29
Symbol	tsx/TLRY
Website	https://www.tilray.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-52.47%
EV/EBITDA	27.97x
EV/Sales	0.55x
FCF / EV yield	-22.07%
FCF yield	-29.75%
Forward P/E	15.94x
Industry forward P/E	34.38x
P/B ratio	0.25x
P/S ratio	0.41x
Price / tangible book value	0.48x
Price/EBITDA ratio	31.47x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-6.02%
EBITDA margin	1.32%
Gross margin	29.35%
Operating margin	-6.02%
Pretax margin	-13.04%
Profit margin	-17.05%
Profit per employee	CAD -63,328
Revenue per employee	CAD 371,407
ROA	-1.64%
ROA (5Y)	-1.95%
ROCE	-3.06%
ROE	-9.38%
ROE (5Y)	-29.74%
ROIC	-3.29%
ROIC (5Y)	-3.83%
SBC / revenue	4.93%
Tax / revenue	2.19%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	1
Gross profit growth	17.88%
Gross profit growth (Q)	34.87%
Gross profit growth 3Y	23.23%
Gross profit growth 5Y	15.22%
Net income growth years	1
Revenue growth	15.93%
Revenue growth (Q)	22.74%
Revenue growth (QoQ)	-8.72%
Revenue growth 10Y	59.51%
Revenue growth 3Y	13.95%
Revenue growth 5Y	11.31%
Revenue growth quarters	5
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -47.8M
Depreciation and amortization	CAD 98.9M
EBIT	CAD -80.4M
EBITDA	CAD 17.6M
EPS	CAD -1.94
Financing cash flow	CAD 173.5M
Free cash flow	CAD -164.7M
Free cash flow minus SBC	CAD -230.5M
Gross profit	CAD 391.8M
Income taxes	CAD 29.3M
Investing cash flow	CAD -124.1M
Net borrowing	CAD -48.8M
Net cash flow	CAD -64.4M
Net income	CAD -227.7M
Operating cash flow minus SBC	CAD -182.7M
Operating income	CAD -80.4M
Revenue	CAD 1.3B
Stock-based compensation	CAD 65.8M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-1.69
Book value per share	CAD 15.65
Debt / EBITDA	19.56
Debt / equity	0.23
Goodwill	CAD 1.1B
Interest coverage	-2.02
Long-term assets	CAD 2.1B
Long-term liabilities	CAD 397.6M
Net cash (debt)	CAD -213.4M
Net cash / market cap	-38.54%
Net debt / EBITDA	12.13
Net debt / equity	0.1
Piotroski F-Score	4
Property, plant and equipment	CAD 990.2M
Shareholders' equity	CAD 2.2B
Tangible book value	CAD 1.1B
Tangible book value per share	CAD 7.99
Total assets	CAD 3.2B
Total cash	CAD 302.2M
Total debt	CAD 515.6M
Total liabilities	CAD 1B
WACC	10.6%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.44
Current assets	CAD 1.1B
Current liabilities	CAD 602.4M
Current ratio	1.88
Inventory turnover	2.22
Net working capital	CAD 352.4M
Quick ratio	0.95
Working capital	CAD 522.5M
Working capital turnover	3.3

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-26.7%
Shareholder yield	-26.7%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 6.71
1D price change	-1.34%
1M price change	-34.74%
1M total return	-34.74%
1W price change	-9.27%
1W total return	-9.27%
1Y price change	-80.73%
1Y return CAGR	-80.75%
1Y total return	-80.73%
20-day SMA	CAD 4.51
200-day SMA	CAD 7.67
3M price change	-34.51%
3M total return	-34.51%
3Y price change	-84.37%
3Y return CAGR	-46.13%
3Y total return	-84.37%
50-day SMA	CAD 5.41
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 21.57
52-week high date	2025-12-18
52-week low	CAD 3.68
52-week low date	2026-10-29
5Y price change	-97.13%
5Y return CAGR	-50.84%
5Y total return	-97.13%
6M price change	-58.48%
6M total return	-58.48%
All-time high	CAD 278.80
All-time high date	2021-06-09
All-time low	CAD 3.67
All-time low date	2026-10-29
Average true range (ATR)	CAD 0.21
Average volume	707.5K
Beta (5Y)	1.92
Change from 52-week high	-82.89%
Change from 52-week low	0.41%
Change from all-time high	-98.67%
Change from all-time low	0.82%
Change from open	-1.34%
Day's gap	0%
Dollar volume	CAD 1.9M
High price	CAD 3.76
Low price	CAD 3.67
Monthly RSI	33.03
Open price	CAD 3.74
Position in 52-week range	22.22%
Previous close	CAD 3.74
Price vs 150-day SMA	-44.58%
Price vs 20-day SMA	-17.46%
Price vs 200-day SMA	-51.52%
Price vs 50-day SMA	-31.19%
Relative volume	0.75
RSI	20.93
Sharpe ratio	-1.74
Sharpe ratio (3Y)	-0.27
Sharpe ratio (5Y)	-0.41
Sortino ratio	-2.76
Sortino ratio (3Y)	-0.42
Sortino ratio (5Y)	-0.61
Volume	528.3K
Weekly RSI	25.39
YTD price change	-70.02%
YTD total return	-70.02%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	144.4M
Shares change (QoQ)	15.43%
Shares change (YoY)	26.7%
Shares held by insiders	1.57%
Shares held by institutions	8.46%
Short % of float	0.98%
Short % of shares	0.98%
Short ratio	5.1 days

Deeper analysis on TSX/TLRY

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSX/TLRY report

Is a complete TSX/TLRY research report available?

No complete published report is available for tsx/TLRY (TSX/TLRY) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSX/TLRY (TSX/TLRY)

Price

Financial snapshot

Fair-value bridge

Latest news · TSX/TLRY

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSX/TLRY indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSX/TLRY

Frequently asked questions